BLLN BillionToOne, Inc.
Company Analysis
Latest News
🟢 BillionToOne is trading 10% up today on an unattributed move
BillionToOne is trading 10% higher at $125.98 on an unattributed trading move. - No clear company-specific announcement or event dated September 24, 2026...
🟢 BillionToOne is trading 5% up today despite biotech and broader-market weakness
BillionToOne is trading 5.19% higher at $120.36, with no new company announcement or clearly attributable catalyst identified. - The advance comes despite...
🟢 BillionToOne is trading 10.23% up today amid XBI’s 2.07% gain
BillionToOne is trading 10.23% up now at $114.49, supported by broader biotech-sector strength, while no clear company-specific announcement has been...
🟢 BillionToOne is trading 4.18% up today — catalyst remains unclear
BillionToOne is trading 4.18% up at $108.20 on September 22, 2026; no company-specific announcement directly explaining the gain was identified. - General...
🔴 BillionToOne is trading 4.03% down today after CEO sold his entire directly held stake
BillionToOne is trading 4.03% down at $106.21 after disclosure that CEO Oguzhan Atay sold 30,331 shares worth approximately $3 million on September 14,...
🟢 BillionToOne rises 4.0% — Biotech Sector Rallies on Strong Industry Outlook and M&A Optimism
With Biotech (XBI) up 2.5%, this looks like a sector-led move rather than a company-specific surprise. The biotechnology sector, as measured by the XBI ETF,...
🟢 BillionToOne is trading 4.48% up today despite weaker broader-market and biotech conditions
BillionToOne is trading 4.48% up at $105.34 despite weaker broader-market and biotech-sector conditions on September 15, 2026; no company-specific announcement...
BillionToOne Executives Sell $2.1M in Stock, as Growth Concerns Hit Shares
BillionToOne, Inc. executives sold significant company stock on September 12, 2026. Chief Technology Officer David Tsao sold shares valued at approximately...
🔴 BillionToOne is trading 4.02% down in pre-market — no clear company-specific catalyst identified
BillionToOne is trading 4.02% down at $95.50 in pre-market, with no clear company-specific overnight catalyst identified. - It closed at $99.50 on September...
BillionToOne Rated Buy at Canaccord, Citing Exceptional Growth and Profitability
Canaccord Genuity initiated coverage of BillionToOne Inc. (NASDAQ: BLLN) with a Buy rating. The investment firm established a price target of...
🟢 BillionToOne is trading 4.04% up today after Northstar Origin launch
BillionToOne is trading 4.04% up at $96.05 following the September 1, 2026 launch of Northstar Origin. - Northstar Origin is a liquid-biopsy add-on predicting...
🟢 BillionToOne is trading 4.22% up today on Northstar Origin launch
BillionToOne is trading at $94.50, up +4.22%, driven by the Northstar Origin launch. - Launched September 1, 2026, Northstar Origin is a liquid-biopsy add-on...
🟢 BillionToOne is trading 5% up in pre-market with no clear company-specific catalyst
BillionToOne is trading at $100.00 (+5.10%) in pre-market, with no clear company-specific catalyst identified. - The latest reported insider transaction was a...
🔴 BillionToOne is trading 4.62% down today with no clear catalyst
BillionToOne is trading 4.62% down at $95.45 on August 26, 2026; no clear company-specific announcement, filing, analyst action, or other catalyst explains the...
🟢 BillionToOne rises 4.1% — Biotech Sector Gains Amid Broad Market Rally and Positive Sentiment
With Biotech (XBI) up 2.1%, this looks like a sector-led move rather than a company-specific surprise. The biotech sector, represented by the XBI ETF, is...
🟢 BillionToOne is trading 4.18% up today in an unexplained rebound after August 18 decline
BillionToOne is trading at $95.50, up +4.18%, in what appears to be an unexplained rebound after the August 18 decline. - No new BillionToOne announcement...
🟢 BillionToOne is trading 6.2% up today amid biotech gains on Moderna results
BillionToOne is trading 6.2% up now at $93.46 after recovering from the August 18 decline, primarily as biotech gains 3.73% following favorable investor...
🔴 BillionToOne is trading 4.5% down today as S&P 500 and Nasdaq Composite fall
BillionToOne is trading 4.5% down at $89.71 after opening-session weakness on August 18, 2026, amid broad market weakness. - The S&P 500 is down 0.58% and...
BillionToOne Launches Largest Prenatal Screen, Targeting 50% of Providers
BillionToOne launched its expanded Unity Fetal Risk Screen on August 17, 2026. The 130-gene panel is the largest non-invasive prenatal testing (NIPT) option...
🟢 BillionToOne is trading 4.8% up today after recovering from its August 6 earnings decline
BillionToOne is trading 4.8% up at $97.86 after rebounding from the sharp August 6 earnings-related decline. - Q2 revenue reached $109.4 million, up 64% year...